JP2021531755A5 - - Google Patents

Info

Publication number
JP2021531755A5
JP2021531755A5 JP2021500805A JP2021500805A JP2021531755A5 JP 2021531755 A5 JP2021531755 A5 JP 2021531755A5 JP 2021500805 A JP2021500805 A JP 2021500805A JP 2021500805 A JP2021500805 A JP 2021500805A JP 2021531755 A5 JP2021531755 A5 JP 2021531755A5
Authority
JP
Japan
Prior art keywords
igg1
domain
linker
domain monomer
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021500805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531755A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/041487 external-priority patent/WO2020014542A2/en
Publication of JP2021531755A publication Critical patent/JP2021531755A/ja
Publication of JP2021531755A5 publication Critical patent/JP2021531755A5/ja
Withdrawn legal-status Critical Current

Links

JP2021500805A 2018-07-11 2019-07-11 改変されたFc−抗原結合ドメイン構築物に関する組成物および方法 Withdrawn JP2021531755A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862696724P 2018-07-11 2018-07-11
US62/696,724 2018-07-11
PCT/US2019/041487 WO2020014542A2 (en) 2018-07-11 2019-07-11 Compositions and methods related to engineered fc-antigen binding domain constructs

Publications (2)

Publication Number Publication Date
JP2021531755A JP2021531755A (ja) 2021-11-25
JP2021531755A5 true JP2021531755A5 (https=) 2022-07-15

Family

ID=69142519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500805A Withdrawn JP2021531755A (ja) 2018-07-11 2019-07-11 改変されたFc−抗原結合ドメイン構築物に関する組成物および方法

Country Status (11)

Country Link
US (1) US20210284717A1 (https=)
EP (1) EP3820910A4 (https=)
JP (1) JP2021531755A (https=)
KR (1) KR20210042325A (https=)
CN (1) CN112969717A (https=)
AU (1) AU2019301698A1 (https=)
BR (1) BR112021000393A2 (https=)
CA (1) CA3106254A1 (https=)
IL (1) IL279989A (https=)
MX (1) MX2021000305A (https=)
WO (1) WO2020014542A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202434644A (zh) * 2023-02-07 2024-09-01 大陸商上海齊魯製藥研究中心有限公司 三特異性抗原結合分子及其應用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG175077A1 (en) * 2009-04-07 2011-11-28 Roche Glycart Ag Trivalent, bispecific antibodies
JP6385357B2 (ja) * 2012-11-27 2018-09-05 アジュ ユニバーシティー インダストリー−アカデミック コーオペレイション ファウンデーションAjou University Industry−Academic Cooperation Foundation 抗体重鎖不変部位の異種二量体、高効率の形成を誘導するch3ドメイン変異体対、その作製方法および用途
EP4299595A3 (en) * 2014-05-02 2024-03-13 Momenta Pharmaceuticals, Inc. Compositions and methods related to engineered fc constructs
EP3227332B1 (en) * 2014-12-03 2019-11-06 F.Hoffmann-La Roche Ag Multispecific antibodies
WO2016172485A2 (en) * 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
EP3423572B1 (en) * 2016-03-02 2023-11-29 Momenta Pharmaceuticals, Inc. Methods related to engineered fc constructs
DK3484514T3 (da) * 2016-05-23 2024-01-29 Momenta Pharmaceuticals Inc Compositions and methods related to engineered fc constructs
WO2018129397A1 (en) * 2017-01-06 2018-07-12 Momenta Pharmaceuticals, Inc. Compositions and methods related to engineered fc-antigen binding domain constructs

Similar Documents

Publication Publication Date Title
RU2019124709A (ru) КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА
JP2020048564A5 (https=)
JP2022512649A5 (https=)
JP2021534096A5 (https=)
HRP20181069T1 (hr) Antagonistička protutijela na il-17
JP2022504802A5 (https=)
JP2019525738A5 (https=)
JP2020508655A5 (https=)
JP2022521705A5 (https=)
JP2016533763A5 (ja) ヒトpd−1に特異的に結合する抗体抗原結合ドメインおよびそれを含む医薬組成物
JP2018516546A5 (https=)
JP2019122405A5 (https=)
JP2009537608A5 (https=)
JP2021514396A5 (https=)
JP2019501883A5 (https=)
JP2018522541A5 (https=)
JP2022516881A5 (https=)
JP2017169559A5 (https=)
JP2021531268A5 (https=)
JP2018526981A5 (https=)
JP2020524000A5 (https=)
RU2009120699A (ru) Гуманизированные антитела к фактору d и их применения
JP2018507188A5 (https=)
JP2012501670A5 (https=)
HRP20241013T1 (hr) Protutijela za kelatirane radionuklide